In 'The Patent Technology Award Ceremony for the first half of 2009' held on 30 June by Korea Intellectual Property Office(KIPO) and JoongAng IIbo, 'Slimmer' is awarded 'the Chungmugong Prize' (the second highest prize).
'Slimmer' is the first new improved drug of Sibutramine mesilate(HM70106) in the world.
And its releated technology is currently patented in 13 countries around the world.
About the reason of selecting 'Slimmer' as a prize awardee, KIPO explained, “From the composition of raw materials to the completion of product, its all processes of producing are done by 100% domestic technology which is exported to foreign countries." <헬스코리아뉴스>
저작권자 © 헬스코리아뉴스 무단전재 및 재배포 금지